MedPath

Teriparatide

Generic Name
Teriparatide
Brand Names
Forsteo, Forteo, Movymia, Kauliv, Sondelbay, Teriparatide Sun, Terrosa, Livogiva
Drug Type
Biotech
CAS Number
52232-67-4
Unique Ingredient Identifier
10T9CSU89I

Overview

Teriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. It is made up of the first amino(N)-terminal 34 amino acids of the human PTH. First approved in the United States in November 2002 and in Europe in April 2003, teriparatide makes the first approved drug in a new category of osteoporosis therapy called anabolic therapy. Teriparatide is used in the treatment of osteoporosis in men and women.

Indication

Teriparatide is indicated:

Associated Conditions

  • Osteoporosis
  • Osteoporosis caused by Glucocorticoid Treatment
  • Primary Osteoporosis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Eli Lilly and Company
0002-8400
SUBCUTANEOUS
250 ug in 1 mL
4/29/2021
Apotex Corp.
60505-6188
SUBCUTANEOUS
250 ug in 1 mL
1/30/2024
Alvogen, Inc.
47781-652
SUBCUTANEOUS
250 ug in 1 mL
8/22/2017
Prasco Laboratories
66993-495
SUBCUTANEOUS
250 ug in 1 mL
11/17/2023
Teva Pharmaceuticals USA, Inc.
0093-1106
SUBCUTANEOUS
250 ug in 1 mL
11/1/2021

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SONDELBAY INJECTION 20 MCG/80 MCL
SIN16802P
INJECTION, SOLUTION
20 mcg/80μl
6/1/2023
FORTEO INJECTION 20 mcg/80mcL
SIN12593P
INJECTION, SOLUTION
750 mcg/3 ml
9/27/2004
MEGAPTH-G SOLUTION FOR INJECTION 20 MCG/80MCL CARTRIDGE PACK
SIN17051P
INJECTION, SOLUTION
20 mcg/80 mcl
7/24/2024
MEGAPTH-G SOLUTION FOR INJECTION 20 MCG/80MCL PEN + CARTRIDGE PACK
SIN17052P
INJECTION, SOLUTION
20 mcg/80 mcl
7/24/2024
TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL
SIN17077P
INJECTION, SOLUTION
20 mcg/80 mcL
9/10/2024

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Teriparatide Injection
国药准字S20220015
生物制品
注射剂
4/19/2022
Teriparatide Injection
国药准字S20240004
生物制品
注射剂
1/16/2024
Teriparatide Injection
国药准字SJ20170032
生物制品
注射剂
9/10/2024
Teriparatide Injection
国药准字S20240005
生物制品
注射剂
2/6/2024
Recombinant Teriparatide for Injection
国药准字S20190037
生物制品
注射剂
9/29/2019
Recombinant Teriparatide for Injection
国药准字S20170004
生物制品
注射剂
11/22/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath